DiNuzzo Private Wealth
AMRX icon

DiNuzzo Private Wealth’s Amneal Pharmaceuticals AMRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$564 Buy
28
+2
+8% +$36 ﹤0.01% 1059
2026
Q2 		$451 Buy
26
+1
+4% +$14 ﹤0.01% 1124
2026
Q1 		$311 Hold
25
– – ﹤0.01% 1184
2025
Q4 		$315 Buy
25
+3
+14% +$34 ﹤0.01% 1190
2025
Q3 		$211 Hold
22
– – ﹤0.01% 1257
2025
Q2 		$178 Buy
22
+19
+633% +$143 ﹤0.01% 1263
2025
Q1 		$26 Hold
3
– – ﹤0.01% 1357
2024
Q4 		$24 Buy
+3
New +$25 ﹤0.01% 1394

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

DiNuzzo Private Wealth's AMRX Position: Q3 2026 in Review

DiNuzzo Private Wealth increased its Amneal Pharmaceuticals (AMRX) stake by 7.7% in Q3 2026, buying an estimated $36 and bringing the position to 28 shares worth $564. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

DiNuzzo Private Wealth first reported a position in AMRX in Q4 2024 and has held it in 8 quarters since. 43 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • DiNuzzo Private Wealth held 28 shares of Amneal Pharmaceuticals worth $564 as of Q3 2026.
  • DiNuzzo Private Wealth bought 2 Amneal Pharmaceuticals shares in Q3 2026, an estimated $36.
  • Amneal Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1059 holding.
  • DiNuzzo Private Wealth first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 43 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.